| Health / Medical Topics |
Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327
An orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits several members of the epidermal growth factor receptor (EGFR) family, including EGFR, HER2 and HER4; Src family kinases (Lyn, Yes, Fyn, Lck and Src); and vascular endothelial growth factor receptor type 3 (VEGFR3). By inhibiting several different signaling molecules that play crucial roles at various stages in tumorigenesis, this agent may inhibit tumor growth, invasion, migration and metastasis. In addition, JNJ-26483327 crosses the blood-brain barrier (BBB). (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of several types of cancer. Multitargeted receptor tyrosine kinase inhibitor ABT-869 blocks the action of…
Having ancestors of several or various races.
A standard file format for transferring non-textual data over the internet.
A cell that can only differentiate to a particular type of cells (e.g. hematopoietic cells or epithelial cells). --2005
A specialized, self-renewing cell in the bone marrow that has the capacity to differentiate into a cell with a particular function, but…
A specialized, self-renewing cell in the bone marrow that has the capacity to differentiate into a cell with a particular function. …
